Noncutaneous immune-related adverse events predict overall and progression-free survival in patients with cutaneous toxicities after immune checkpoint inhibitor therapy Research Letter
| Authors: | Asdourian, M. S.; Jacoby, T. V.; Shah, N.; Otto, T.; Thompson, L. L.; Dee, E. C.; Reynolds, K. L.; Semenov, Y. R.; Chen, S. T. |
| Title: | Noncutaneous immune-related adverse events predict overall and progression-free survival in patients with cutaneous toxicities after immune checkpoint inhibitor therapy |
| Keywords: | aged; major clinical study; overall survival; skin toxicity; cancer immunotherapy; progression free survival; retrospective study; immune response; immunotherapy; immunopathology; progression-free survival; clinical outcome; dermatologic toxicity; immune checkpoint inhibitor; cancer prognosis; human; male; female; article; oncodermatology; cutaneous immune-related adverse event; multisystem toxicity; noncutaneous immune-related adverse event |
| Journal Title: | Journal of the American Academy of Dermatology |
| Volume: | 88 |
| Issue: | 6 |
| ISSN: | 0190-9622 |
| Publisher: | Mosby Elsevier |
| Date Published: | 2023-06-01 |
| Start Page: | 1368 |
| End Page: | 1370 |
| Language: | English |
| DOI: | 10.1016/j.jaad.2022.12.049 |
| PUBMED: | 36736625 |
| PROVIDER: | scopus |
| DOI/URL: | |
| Notes: | Article -- MSK Cancer Center Support Grant (P30 CA008748) acknowledged in PDF and PubMed -- Source: Scopus |
